Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer’s Biomarker Profiling
Alamar Biosciences announced that its NULISA platform and related assays are featured in over 140 scientific presentations at the 2026 Alzheimer's Association International Conference, highlighting widespread adoption and progress in multiplex protein profiling for early Alzheimer's disease detection and staging. The platform's ability to measure m…